Compare Amphastar Pharmaceuticals Inc (AMPH) vs Fiverr International Ltd (FVRR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Fiverr International Ltd — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Fiverr International Ltd trades at $10.97 (market cap $396.90M). The key difference: Amphastar Pharmaceuticals Inc is far larger — about 2.1× Fiverr International Ltd's market cap. Which is the better fit depends on your goals.
| AMPH | FVRR | |
|---|---|---|
Market Cap | $826.08M | $396.90M |
Sector | Health | Industrials |
52-Week High | $30.81 | $27.25 |
52-Week Low | $16.87 | $9.62 |
Enterprise Value | $1.22B | $127.50M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Fiverr International (FVRR) trades at $11.04, up 1.1% on the day, with a bullish technical signal and strong valuation metrics including a P/E of 14.34 and P/S of 0.95. Revenue grew to $430.91M in 2025, with net income reaching $20.98M, though Q1 2026 EPS missed expectations. The company maintains a robust gross margin of 81.86% and has beaten earnings estimates in two of the last three quarters, with Q2 2026 results due July 29, 2026.
The outlook is mixed: low valuations and improving profitability support upside, but declining active buyers and a pending legal investigation pose risks. Analyst consensus is cautious with 41% buy ratings. Near-term performance hinges on Q2 earnings demonstrating growth stabilization amid competitive pressures in the gig economy.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →
